Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NM › Los Lunas › NPI 1568704237
Clinic

Bella Vida Health Care and Medi Spa

Bella Vida Health Care and Medi Spa was paid $7.18M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.

33Billing provider infoBELLA VIDA HEALTH CARE AND MEDI SPA
LOS LUNAS, NM 87031
33aNPI1568704237assigned 03/20/2013
28Total paid$7.18M
24GClaims127,554
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Health Service Clinic/Center providers in New Mexico

Rank by total paid#1 of 17
Median peer was paid$243K
This provider vs. median29×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201823,290$919K
201918,356$1.00M
202012,315$769K
202116,044$935K
202219,869$1.07M
202320,461$1.25M
2024incomplete17,219$1.23M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 45% 47,114 45,951 $3.20M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 39% 29,240 28,117 $2.78M
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 9.3% 6,890 6,845 $670K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.9% 8,387 8,331 $135K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.1% 3,333 2,451 $78K
36415 Collection of venous blood by venipuncture <1% 8,344 8,104 $38K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 375 374 $34K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 238 237 $34K
99173 <1% 768 765 $29K
99051 <1% 892 864 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,601 1,480 $28K
81003 <1% 12,141 11,916 $26K
38 more codes
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 237 $24K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 124 $12K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,014 $11K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 107 $10K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 149 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 223 $8K
81025 <1% 788 $7K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 39 $4K
87807 <1% 162 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 228 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 80 $2K
93000 <1% 115 $1K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 13 $1K
A7015 Aerosol mask, used with dme nebulizer <1% 724 $1K
82947 <1% 299 $1K
82043 <1% 192 $982.54
90472 Immunization administration, each additional vaccine (list separately) <1% 21 $784.02
90460 Immunization administration through 18 years of age via any route, first or only component <1% 22 $560.69
98968 <1% 13 $368.74
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 87 $178.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 366 $164.91
96127 <1% 14 $126.75
85018 <1% 57 $123.23
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 510 $70.25
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 14 $54.19
82962 <1% 12 $31.76
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 86 $3.62
J8540 Dexamethasone, oral, 0.25 mg <1% 13 $0.64
3210F 0% 138 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 296 $0.00
3725F 0% 13 $0.00
3077F 0% 12 $0.00
4120F 0% 12 $0.00
4013F 0% 13 $0.00
3008F 0% 985 $0.00
1220F 0% 844 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 0% 125 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 0% 84 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHAVEZ, FRANK (OPERATIONS)